FDA Recalls Supplements Sold on Amazon Over Contamination Concerns

Laboratory analysis by the FDA confirmed that the product contains the active ingredients omeprazole and diclofenac.

A bottle of the Umary supplement under recall. FDA

On Nov. 21, the U.S. Food and Drug Administration (FDA) announced the recall of hyaluronic acid supplements sold on Amazon.

The company MXBBB is voluntarily recalling one lot of “Umary” acid hyaluronic, 30 caplets (850 mg), for consumers. Laboratory analysis by the FDA confirmed that the product contains the active ingredients omeprazole and diclofenac.

What Are Diclofenac and Omeprazole?

Diclofenac, an NSAID (non-steroidal anti-inflammatory drug), poses potential risks such as increased cardiovascular events, including heart attack and stroke, and severe gastrointestinal damage, such as bleeding, ulcers, and potentially fatal perforation of the stomach and intestines.